JAMA Internal Medicine published a clinical update in Research Highlights on 01 Mar 2026. The item focuses on Remove Oral Diphenhydramine from OTC. Review the original article for the full source wording and details.
This Viewpoint describes adverse events associated with diphenhydramine and advocates for its withdrawal from over-the-counter (OTC) allergy medications.